Binding of Trastuzumab to ErbB2 Is Inhibited by a High Pericellular Density of Hyaluronan
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Binding of Trastuzumab to ErbB2 Is Inhibited by a High Pericellular Density of Hyaluronan
Authors
Keywords
-
Journal
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 60, Issue 8, Pages 567-575
Publisher
SAGE Publications
Online
2012-05-06
DOI
10.1369/0022155412448070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
- (2011) Hiroshi Urakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Oesophageal Squamous Cell Carcinoma Progression by in vivo Targeting of Hyaluronan Synthesis
- (2011) Sören Twarock et al. Molecular Cancer
- Biological hydrogels as selective diffusion barriers
- (2011) Oliver Lieleg et al. TRENDS IN CELL BIOLOGY
- Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer
- (2010) Toru Mukohara CANCER SCIENCE
- Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
- (2010) J. Sperinde et al. CLINICAL CANCER RESEARCH
- Hyaluronan in human malignancies
- (2010) R.K. Sironen et al. EXPERIMENTAL CELL RESEARCH
- Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy
- (2010) Sarah J. Storr et al. INTERNATIONAL JOURNAL OF CANCER
- Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
- (2010) C. B. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer
- (2009) Bert van der Vegt et al. MODERN PATHOLOGY
- HER-2/neu expression in primary and metastatic breast cancer
- (2008) Elyse E. Lower et al. BREAST CANCER RESEARCH AND TREATMENT
- EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44
- (2008) Zsuzsanna Pályi-Krekk et al. CANCER LETTERS
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Targeted therapies in breast cancer: Where are we now?
- (2008) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- The role of Neuregulin-1β/ErbB signaling in the heart
- (2008) Laura Pentassuglia et al. EXPERIMENTAL CELL RESEARCH
- Pericellular Hyaluronan Coat Visualized in Live Cells With a Fluorescent Probe Is Scaffolded by Plasma Membrane Protrusions
- (2008) Kirsi Rilla et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Altered hyaluronan biosynthesis in cancer progression
- (2008) Naoki Itano et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now